Division of Pediatric Urology, Brady Urological Institute, Johns Hopkins Medical Institutions, Baltimore, MD, USA.
BJU Int. 2013 May;111(5):828-33. doi: 10.1111/j.1464-410X.2012.11319.x. Epub 2012 Aug 3.
WHAT'S KNOWN ON THE SUBJECT? AND WHAT DOES THE STUDY ADD?: Continent urinary diversion with bladder augmentation is an established method of providing urinary continence in children with bladder exstrophy, who are not suitable candidates or have a failed bladder neck reconstruction. Sub-mucosal implantation of the tubularized catheterizable stoma (usually the appendix) into the reservoir, with backing typically provided by either the bladder musculature or colonic taenia, is safe and highly effective in these children. In some cases of classic bladder exstrophy and in the majority of patients with cloacal exstrophy, the ileum is used for enterocystoplasty and therefore there is no taenia to back the implanted catheterizable channel. This study describes the steps for providing a reliable flap-valve mechanism for the continent catheterizable channel using the serosal trough technique.
To evaluate the efficacy and potential complications of the serosal-trough (ST) technique for the implantation of a continent catheterizable stoma (CCS) during enterocystoplasty. To describe the surgical technique and provide detailed illustrations.
Using an institutional review board-approved departmental database, children with bladder exstrophy, born after 1990, were selected, and patients who had undergone urinary diversion with a CCS created using the ST technique were identified. Demographic and technical characteristics, as well as the eventual clinical outcomes, were retrospectively reviewed.
A total of 135 patients with urinary diversion were identified, of whom 26 (13 males) had undergone CCS implantation using the ST technique. Patients included 14 classic exstrophies, 10 cloacal exstrophies, and two epispadias. The appendix and tapered ileum were used for the creation of a CCS in 11 and 15 patients, respectively. The median (range) age at creation of a CCS was 10.7 (4.4-17.4) years. At the time of CCS creation, 21 patients underwent initial enterocystoplasty, four had repeat augmentations, and one had a CCS on a previously augmented bladder. Ileum (mean length 18 cm) was used in 24/25 augmentations and was selected owing to lack of redundant sigmoid in 52% of patients and intraoperative surgeon preference in the remaining cases. In one case of cloacal exstrophy, a hindgut remnant was used. In 24 (92%) cases, initial CCS resulted in complete continence of the catheterizable channel. After a median (range) of 2.5 (0.2-7.5) years' follow-up all patients were dry via intermittent catheterization. The CCS failed at postoperative months 6 and 21 and required complete revision in two cases.
Using a ST to provide a strong backing for a catheterizable channel is an excellent option when a channel must be placed in the ileum, hindgut, or in an area of augmentation where muscular backing is not available. The ST technique provides a reliably catheterizable tunnel, durable continence mechanism and a good success rate when creating a CCS in combination with a urinary diversion.
评估在肠膀胱成形术中使用浆膜下槽(ST)技术植入可控性膀胱造口(CCS)的疗效和潜在并发症。描述手术技术并提供详细说明。
使用机构审查委员会批准的部门数据库,选择了 1990 年后出生的膀胱外翻患者,并确定了接受使用 ST 技术进行 CCS 植入的尿路分流术的患者。回顾性回顾了人口统计学和技术特征以及最终的临床结果。
确定了 135 例接受尿路分流术的患者,其中 26 例(13 名男性)接受了使用 ST 技术的 CCS 植入。患者包括 14 例经典型外翻、10 例会阴型外翻和 2 例尿道下裂。11 例患者使用阑尾和锥形回肠创建 CCS,15 例患者分别使用阑尾和锥形回肠创建 CCS。CCS 创建时的中位(范围)年龄为 10.7(4.4-17.4)岁。在 CCS 创建时,21 例患者接受了初始肠膀胱成形术,4 例患者接受了重复增强,1 例患者在先前增强的膀胱上进行了 CCS。24/25 例增强术中使用了回肠(平均长度 18cm),52%的患者因缺乏冗余乙状结肠而选择,其余病例则因术中外科医生偏好而选择。在一例会阴型外翻中,使用了后肠残段。在 24 例(92%)病例中,初始 CCS 导致可控通道完全失禁。在中位(范围)2.5(0.2-7.5)年的随访后,所有患者均通过间歇性导尿保持干燥。CCS 在术后第 6 个月和第 21 个月失败,需要完全修复 2 例。
当通道必须放置在回肠、后肠或增强区域,而肌肉支撑不可用时,使用 ST 为可控性通道提供强有力的支撑是一种极好的选择。当与尿路分流术联合使用时,ST 技术为 CCS 的创建提供了可靠的可导尿隧道、持久的控尿机制和较高的成功率。